RegeneRx announces the receipt of a Notice of Allowance in Europe for its patent application (News-Medical-Net)
RegeneRx announces the receipt of a Notice of Allowance in Europe for its patent application (News-Medical-Net)
REGENERX BIOPHARMACEUTICALS, INC. (the Company or RegeneRx ) announced today that it received a Notice of Allowance in Europe for its patent application: Inhibition or Reversal of Skin Aging by Actin-Sequestering Peptides.